As shown from the demographics and baseline characteristics summarized in Supplementary Table 1, clinical tumor markers, such as CEA, CA19-9, CA15-3, SCC and CYFRA21-1, did not present sufficient specificity (SP) and SE for diagnosing ESCC. The gene discussed is CEACAM5; the disease is neoplasm.